NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









Rambam AG

Rambam AG

Zugrambam.ch

Overview

Rambam AG is a Swiss-based venture studio and accelerator platform focused on breakthrough drug discovery and development.

Year Founded

2021

Portfolio Companies

1

Website

rambam.ch

Investments

Rambam AG investments
CompanyDateStageLead
NeurOdys TherapeuticsMar 2026Pre SeedLead

Key People

Rouslan Michtchenko

Global Executive Director

Sanja Tomovska

Venture Partner Strategic Growth EU

Sector & Stage Mix

Industry, funding stage, and valuation band breakdowns.

Premium
SeedSeries ASeries BGrowth

Unlock portfolio analytics

Sign up to view full sector, stage, and valuation breakdowns for this investor.

Investment Activity

Yearly cadence, pace, and funding raised over time.

Premium
2021
2022
2023
2024
2025
2026

Unlock portfolio analytics

Sign up to explore yearly investment trends and funding raised over time.

FAQ

Firmographic Details

HeadquartersZug
Year Founded2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.